Kamel Chettab
Impact in
-
- HER2/EGFR in Cancer Research
Papers in
-
- RNA Interference and Gene Delivery 3
- Oncology 8
- HER2/EGFR in Cancer Research 5
- Co-authors
- Charles Dumontet (23 shared papers)Eva‐Laure Matera (11 shared papers)Minh Ngoc Duong (2 shared papers)Béatrice Clemenceau (1 shared paper)Sandrine Valsesia‐Wittmann (1 shared paper)Lars Petter Jordheim (11 shared papers)Jean‐Louis Mestas (5 shared papers)Maxime Lafond (5 shared papers)
- Journals
- Thrombosis and Haemostasis (3 papers)Molecular Cancer Therapeutics (2 papers)Molecular Pharmaceutics (2 papers)Oncotarget (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Kamel Chettab
29 papers receiving 478 citations
Peers
Comparison fields: 5 of 72
- Oncology 142
- Endocrinology 23
- Cancer Research 67
- Immunology 81
- Virology 13
Countries citing papers authored by Kamel Chettab
This map shows the geographic impact of Kamel Chettab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Chettab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Chettab more than expected).
Fields of papers citing papers by Kamel Chettab
This network shows the impact of papers produced by Kamel Chettab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Chettab. The network helps show where Kamel Chettab may publish in the future.
Co-authors
The 25 scholars most cited alongside Kamel Chettab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 91 | |
| 2 | 2006 | 41 | |
| 3 | 1998 | 37 | |
| 4 | 2013 | 25 | |
| 5 | 2002 | 25 | |
| 6 | 2018 | 23 | |
| 7 | 2001 | 22 | |
| 8 | 2017 | 21 | |
| 9 | 2022 | 18 | |
| 10 | 2015 | 18 | |
| 11 | 2020 | 16 | |
| 12 | 2017 | 14 | |
| 13 | 2013 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2016 | 11 | |
| 17 | 2023 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2017 | 10 | |
| 20 | 2018 | 8 |
About Kamel Chettab
Kamel Chettab is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 31 papers that have together received 479 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Cell Adhesion Molecules Research (5 papers), Ultrasound and Hyperthermia Applications (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Sarcoma Diagnosis and Treatment (3 papers), RNA Interference and Gene Delivery (3 papers) and Ultrasound Imaging and Elastography (2 papers). The work is most often cited by research in Oncology (142 citations), Endocrinology (23 citations), Cancer Research (67 citations), Immunology (81 citations) and Virology (13 citations). Kamel Chettab has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Charles Dumontet, Eva‐Laure Matera, Minh Ngoc Duong, Béatrice Clemenceau, Sandrine Valsesia‐Wittmann, Lars Petter Jordheim, Jean‐Louis Mestas, Maxime Lafond, Cyril Lafon and Kazem Zibara. Their work appears in journals such as Thrombosis and Haemostasis, Molecular Cancer Therapeutics, Molecular Pharmaceutics, Oncotarget and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.